Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Bayer CEO says his team retains backing of supervisory board: report

Published 03/24/2019, 08:59 AM
Updated 03/24/2019, 09:00 AM
© Reuters. FILE PHOTO: Werner Baumann, CEO of Bayer AG poses for a picture during the annual results news conference of the German drugmaker in Leverkusen

© Reuters. FILE PHOTO: Werner Baumann, CEO of Bayer AG poses for a picture during the annual results news conference of the German drugmaker in Leverkusen

FRANKFURT (Reuters) - Bayer's management retains the backing of its supervisory board, its chief executive said, after pressure on the company increased when a second jury in the United States ruled its glyphosate-based Roundup weed killer caused cancer.

Bayer (DE:BAYGN), which denies allegations that glyphosate or Roundup cause cancer, acquired Monsanto (NYSE:MON), the maker of Roundup, for $63 billion last year.

Its shares have fallen a third over the last 12 months burdened by thousands of lawsuits over a suspected cancer link to Roundup.

"The share price is significantly impacted by the legal cases related to glyphosate in America, the discounts are greatly exaggerated," Chief Executive Werner Baumann told Frankfurter Allgemeine Sonntagszeitung (FAS).

"The management board enjoys the full backing of the supervisory board," added Baumann, who has been Bayer CEO for almost three years.

A U.S. jury last week found that Roundup caused cancer, a blow to the company eight months after another jury issued a $289 million verdict over similar claims in a different case. That award was later reduced to $78 million and is on appeal.

Baumann defended Bayer's move to acquire Monsanto, saying it "was and is a good idea", according to the FAS interview.

Asked about a potential breakup of Bayer, Baumann said the group had a clear strategy based on three divisions -- pharmaceuticals, crop science and consumer health.

"We want to strategically develop these three pillars, all three markets are attractive."

© Reuters. FILE PHOTO: Werner Baumann, CEO of Bayer AG poses for a picture during the annual results news conference of the German drugmaker in Leverkusen

Talk of a break-up has been fueled since it emerged in December that activist fund Elliott had taken a stake.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.